Patient Monitoring in the Intensive Care Unit
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05847803
Collaborator
(none)
240
1
3.3
73.8
Study Details
Study Description
Brief Summary
a cross-sectional survey of nurses' perception of patient monitoring in the ICUs
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
240 participants
Observational Model:
Case-Crossover
Time Perspective:
Cross-Sectional
Official Title:
Nurses' Perceptions of Patient Monitoring in the Intensive Care Unit: a Cross-sectional Study
Actual Study Start Date
:
Feb 5, 2023
Anticipated Primary Completion Date
:
Apr 30, 2023
Anticipated Study Completion Date
:
May 15, 2023
Outcome Measures
Primary Outcome Measures
- clinical requirements of patient monitoring in ICUs [12 months of working]
Assessed using a web-based 36-item survey questionnaire Patient Monitoring in the Intensive Care Unit
- Work-related flow in ICUs [12 months of working]
Assessed using the Work-related Flow inventory (WOLF)
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- registered nurses in the ICUs
Exclusion Criteria:
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | SAHZhejiangU | Hangzhou | China | 310009 |
Sponsors and Collaborators
- Second Affiliated Hospital, School of Medicine, Zhejiang University
Investigators
- Study Chair: Wen Gao, PhD, SAHZU
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Second Affiliated Hospital, School of Medicine, Zhejiang University
ClinicalTrials.gov Identifier:
NCT05847803
Other Study ID Numbers:
- 20230110
First Posted:
May 8, 2023
Last Update Posted:
May 8, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No